Status:
COMPLETED
Does Fluticasone Propionate Reduce the Late Allergic Reaction When the Drug is Given Post-allergen?
Lead Sponsor:
Hamilton Health Sciences Corporation
Collaborating Sponsors:
AstraZeneca
Conditions:
Mild Intermittent Asthma
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
The investigators propose a 3-treatment, placebo-controlled, double-dummy, double-blinded, randomized, crossover study in which single doses of placebo, will be compared to Fluticasone propionate (Flo...
Detailed Description
The aim of this pilot study is to evaluate whether fluticasone propionate affects the late allergic reaction after a single dose post-allergen challenge administered following cessation of the early a...
Eligibility Criteria
Inclusion
- mild asthma
- nonsmokers
- allergen-induced early and late asthmatic response
Exclusion
- no medication other than infrequent ( \< twice weekly) inhaled beta2-agonists
- not be exposed to sensitizing allergens
- asthma exacerbation or respiratory tract infection in the past4 weeks
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00716963
Start Date
July 1 2008
End Date
December 1 2008
Last Update
May 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McMaster University
Hamilton, Ontario, Canada, L8N 3Z5